Abstract
Primary myelofibrosis (PMF) is myeloproliferative neoplasm whose diagnosis is based on a combination of clinical and pathology criteria. We evaluated 560 consecutive patients who were diagnosed with PMF upon a referral to our center and evaluated the frequency of and reasons for diagnostic discordance. Discordance in the diagnosis was found in 70 (12.5%) patients. Discordant cases had a significantly lower grade of bone marrow fibrosis (grade 0-1), more likely to be JAK2V617F-mutation negative, and have no peripheral blood blasts, possibly explaining the difficulty in making a proper diagnosis and underscoring the need for a complete evaluation at a tertiary center.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 91-94 |
| Number of pages | 4 |
| Journal | Leukemia Research |
| Volume | 38 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2014 |
Keywords
- Diagnostic discrepancy
- JAKV617F mutation
- Primary myelofibrosis
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research
MD Anderson CCSG core facilities
- Clinical Trials Office
Fingerprint
Dive into the research topics of 'Discrepancy in diagnosis of primary myelofibrosis between referral and tertiary care centers'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS